title: Antimicrobial resistance among Campylobacter strains, United States, 1997-2001.
abstract: We summarize antimicrobial resistance surveillance data in human and chicken isolates of Campylobacter. Isolates were from a sentinel county study from 1989 through 1990 and from nine state health departments participating in National Antimicrobial Resistance Monitoring System for enteric bacteria (NARMS) from 1997 through 2001. None of the 297 C. jejuni or C. coli isolates tested from 1989 through 1990 was ciprofloxacin-resistant. From 1997 through 2001, a total of 1,553 human Campylobacter isolates were characterized: 1,471 (95%) were C. jejuni, 63 (4%) were C. coli, and 19 (1%) were other Campylobacter species. The prevalence of ciprofloxacin-resistant Campylobacter was 13% (28 of 217) in 1997 and 19% (75 of 384) in 2001; erythromycin resistance was 2% (4 of 217) in 1997 and 2% (8 of 384) in 2001. Ciprofloxacin-resistant Campylobacter was isolated from 10% of 180 chicken products purchased from grocery stores in three states in 1999. Ciprofloxacin resistance has emerged among Campylobacter since 1990 and has increased in prevalence since 1997.
authors.affiliation: Centers for Disease Control and Prevention, Atlanta, Georgia, USA. agupta25@jhmi.edu
authors.forename: Amita
authors.initials: A
authors.lastname: Gupta
authors.forename: Jennifer M
authors.initials: JM
authors.lastname: Nelson
authors.forename: Timothy J
authors.initials: TJ
authors.lastname: Barrett
authors.forename: Robert V
authors.initials: RV
authors.lastname: Tauxe
authors.forename: Shannon P
authors.initials: SP
authors.lastname: Rossiter
authors.forename: Cindy R
authors.initials: CR
authors.lastname: Friedman
authors.forename: Kevin W
authors.initials: KW
authors.lastname: Joyce
authors.forename: Kirk E
authors.initials: KE
authors.lastname: Smith
authors.forename: Timothy F
authors.initials: TF
authors.lastname: Jones
authors.forename: Marguerite A
authors.initials: MA
authors.lastname: Hawkins
authors.forename: Belershacew
authors.initials: B
authors.lastname: Shiferaw
authors.forename: James L
authors.initials: JL
authors.lastname: Beebe
authors.forename: Duc J
authors.initials: DJ
authors.lastname: Vugia
authors.forename: Terry
authors.initials: T
authors.lastname: Rabatsky-Ehr
authors.forename: James A
authors.initials: JA
authors.lastname: Benson
authors.forename: Timothy P
authors.initials: TP
authors.lastname: Root
authors.forename: Frederick J
authors.initials: FJ
authors.lastname: Angulo
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002167:Campylobacter / Q000187:drug effects* / Q000302:isolation & purification; D002169:Campylobacter Infections / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology*; D002645:Chickens / Q000382:microbiology*; D002939:Ciprofloxacin / Q000494:pharmacology* / Q000627:therapeutic use; D024881:Drug Resistance, Bacterial; D005516:Food Microbiology; D006801:Humans; D016015:Logistic Models; D008826:Microbial Sensitivity Tests; D015999:Multivariate Analysis; D012189:Retrospective Studies; D014481:United States / Q000453:epidemiology
chemical_list: D000900:Anti-Bacterial Agents; D002939:Ciprofloxacin